Skip to content

Prospective, multicentric observational study on the application of ASEPT® and on results from patient surveys in palliative care

Prospective, multicentric observational study on the application of ASEPT® and on results from patient surveys in palliative care - PRO ASEPT®

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031242
Enrollment
150
Registered
2023-03-31
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R18 J90 J91 C78.2 C78.6 K70.3 K74.3 K74.4 K74.5 K74.6

Interventions

Group 1: patients requiring pleural or peritoneal drainage

Sponsors

pfm medical gmbh
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: *Medical indication for an ASEPT® Pleural Drainage System or an ASEPT® Peritoneal Drainage System. *Patient is able to grasp the nature, significance, and scope of the PMCF study. *Patient information has been handed out and all written consents have been obtained. *Life expectancy > 2 months.

Exclusion criteria

Exclusion criteria: *Contraindications according to the instructions for use (IFU) of the manufacturer. * Patient is institutionalised by court or official order (MPDG §27). *Patient is participating in another surgical clinical study that also relates to the area of ASEPT® Pleural Drainage System or ASEPT® Peritoneal Drainage System.

Design outcomes

Primary

MeasureTime frame
Evaluation of changes in patients palliative care outcome six weeks after implantation of the ASEPT® Pleural or Peritoneal Drainage System compared to baseline using the Palliative care Outcome Scale (POS) questionnaire.

Countries

Germany

Contacts

Public ContactSabrina Tofall

pfm medical gmbh

sabrina.tofall@pfmmedical.com+49 2236 9641 146

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026